0000000000010774

AUTHOR

Ferrán Catalá-lópez

0000-0002-3833-9312

showing 110 related works from this author

Additional file 2: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Key terms for PubMed/MEDLINE search. (DOCX 28 kb)

3. Good health
researchProduct

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systema…

2020

Publisher's version (útgefin grein)

Index (economics)Servicios de SaludSUSTAINABLE DEVELOPMENT GOALS030204 cardiovascular system & hematologyuniversal health coverage; sustaibale develpment goal; global burden of disease; performance;universal health coveragesystematic analysisGlobal Burden of Disease0302 clinical medicineUniversal Health InsuranceRA042111. SustainabilityPer capitaMedical economicsDisease030212 general & internal medicine10. No inequality11 Medical and Health Scienceseffective coverage of health servicesGBD 2019 Universal Health Coverage Collaboratorseducation.field_of_studyPublic healthMedical careSjúkdómar4. Education1. No povertyHealth coveragePublic Health Global Health Social Medicine and EpidemiologyGeneral MedicineHälsovetenskaper3142 Public health care science environmental and occupational healthHealth services3. Good healthGlobal burden of diseaseGlobal Burden of Disease; Health Expenditures; Humans; Universal Health Insurance; World Health OrganizationPurchasing power parityScale (social sciences)/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLýðheilsauniversal health coveragCANCER SURVIVALACCESSperformanceHumanHeilsuhagfræðimedicine.medical_specialtyHealth coverage GBDGBDUniversal healthGBD 2019Population2019Health expenditures3122 CancersPopulation healthWorld Health Organization03 medical and health sciencesHealth systemsHeilbrigðisvísindiSDG 3 - Good Health and Well-beingGeneral & Internal MedicineDevelopment economicsHealth SciencesmedicineHeilbrigðisstefnasustaibale develpment goalAlþjóðaheilbrigðisstofnuninHumansQUALITYGlobal Burden of Disease StudyeducationPROGRESSDisease burdenPublic healthHealth services accessibilityCAREHeilbrigðisþjónusta//purl.org/pe-repo/ocde/ford#3.02.00 [https]Health ExpenditureFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineMorbilityAdministración de los Servicios de SaludMedical policyBusinessHealth ExpendituresHeilbrigðiskerfi
researchProduct

La Declaración GATHER para la presentación precisa y trasparente de los estudios sobre estimaciones de salud procedentes de múltiples fuentes de info…

2016

03 medical and health sciences0302 clinical medicine030503 health policy & services030212 general & internal medicineGeneral Medicine0305 other medical scienceRevista Española de Salud Pública
researchProduct

Additional file 1: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

PRISMA-P checklist. (DOCX 24 kb)

3. Good health
researchProduct

Additional file 3: of Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic revi…

2019

Methodological Quality Checklist for Prevalence data. (DOCX 29 kb)

researchProduct

Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis

2019

This systematic review and meta-analysis evaluates the association of anorexia nervosa with the cancer incidence and mortality among study populations with anorexia nervosa compared with the general population or those without anorexia nervosa.

AdultMalemedicine.medical_specialtyAnorexia NervosaPopulationbehavioral disciplines and activitiesYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerNeoplasmsInternal medicineObservational studymental disordersHumansMedicine030212 general & internal medicineSex DistributionYoung adulteducationOriginal InvestigationAgedCancereducation.field_of_studybusiness.industryResearchMortality ratedigestive oral and skin physiologyCancerGeneral MedicineMiddle Agedmedicine.disease3. Good healthOnline OnlyMeta-analysisOncologyAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesisMeta-analysisSystematic reviewFemaleEpidemiologic Methodsbusinesshormones hormone substitutes and hormone antagonistsCohort study
researchProduct

Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study…

2014

BACKGROUND: The fifth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100,000 livebirths) between 1990 and 2015. We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery.METHODS: We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to analyse a database of data for 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries between 1990 and 2013. We estimated the number of pregnancy-related deaths caused by HIV on the basi…

PediatricsTime FactorsNutrition and Diseasehiv-infectionimmunodeficiency virus-1 infectionperipartum cardiomyopathyPoison controlHIV InfectionsIMMUNODEFICIENCY VIRUS-1 INFECTIONSocioeconomic FactorGlobal Health0302 clinical medicinePERIPARTUM CARDIOMYOPATHYpregnancy-related mortalityRisk FactorsPregnancyVoeding en ZiekteCause of DeathGlobal healthHIV Infection030212 general & internal medicinePregnancy Complications Infectious10. No inequalityCause of death030219 obstetrics & reproductive medicinesouth-africaMedicine (all)1. No povertyWOMENPREGNANCY-RELATED MORTALITYhealth initiativesGeneral MedicineSOUTH-AFRICA3. Good healthMaternal MortalityWorld HealthCHILD SURVIVALFemaleMaternal deathwomenHumanmedicine.medical_specialtyTime FactorDEATHSchild survivalArticleadult mortality03 medical and health sciencesAge DistributionHEALTH INITIATIVESSDG 3 - Good Health and Well-beingHIV-INFECTIONADULT MORTALITYInjury preventionmedicineOrganizational ObjectivesOrganizational ObjectiveHumansVLAGPregnancyModels Statisticalbusiness.industryRisk Factormedicine.diseasedeathsStandardized mortality ratioSocioeconomic FactorsRelative riskPregnancy Complications InfectioubusinessDemography
researchProduct

[Clinical equipoise and systematic reviews of randomized controlled trials].

2015

.Para poder valorar la validez de un ensayo cli´nico es necesarioque su disen˜o, ejecucio´n y ana´lisis se describan con suficientedetalle, exactitudytransparencia.Sinembargo,existennumerososejemplos en la literatura cienti´fica que ponen de manifiesto co´mola informacio´n facilitada en las publicaciones es muchas vecesdeficiente, y que con frecuencia se presentan problemas metodo-lo´gicos graves

PsychotherapistEvidence-Based Medicinebusiness.industrylaw.inventionClinical equipoiseReview Literature as TopicSystematic reviewRandomized controlled trialMeta-Analysis as TopiclawTherapeutic EquipoiseMedicineHumansbusinessRandomized Controlled Trials as TopicMedicina clinica
researchProduct

Hyperosmolar therapy for acute brain injury: study protocol for an umbrella review of meta-analyses and an evidence mapping

2020

Introduction Acute brain injury is a challenging public health problem worldwide. Elevated intracranial pressure is a common complication after acute brain injury. Hyperosmolar therapy is one of the main therapeutic strategies for the management of intracranial hypertension. This study protocol outlines an umbrella review of meta-analyses which will investigate the benefits and harms of hyperosmolar therapy routinely used for the management of acute brain injury in the intensive care. Methods and analysis We will search PubMed/MEDLINE, EMBASE and the Cochrane Database of Systematic Reviews. We will include meta-analyses of primary research studies (eg, randomised controlled trials, observat…

meta-analysilaw.inventionAnaesthesia0302 clinical medicineHypertonic salinesystematic reviewlawBrain Injuries TraumaticProtocolMedicineMannitol1506030212 general & internal medicineBrain injuryRandomized Controlled Trials as TopicEvidence-Based MedicineRGeneral MedicineIntensive care unit3. Good healthTreatment OutcomeSystematic reviewResearch DesignMeta-analysisMedicinehyperosmolar therapy1682medicine.medical_specialtyCritical CareMEDLINE03 medical and health sciencesMeta-Analysis as TopicIntensive careHumansHyperosmolar therapyCerebral perfusion pressureIntensive care medicineSaline Solution HypertonicDroitbusiness.industrymannitolbrain injuryHypertonic salinemeta-analysisMeta-analysisSystematic reviewFluid TherapyObservational studyIntracranial Hypertensionbusiness030217 neurology & neurosurgeryhypertonic saline
researchProduct

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 3…

2017

Importance: Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning.Objective: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015.Evidence Review: Cancer mortality was estimated using vital registration system data, cancer registry incidence data (transformed to mortality estimates using separately estimated mortality to incidence [MI] ratios), and verbal autopsy data. Cancer incidence was calculated by dividing mortality estimates through the modeled MI ratio…

0301 basic medicineGerontologyCancer ResearchPopulationArticle03 medical and health sciences0302 clinical medicineBreast cancerGlobal healthcancerMedicineDisability-adjusted life yeareducationDisease burdeneducation.field_of_studyestimate mortalityCancer preventioncancer preventionbusiness.industryMortality rate1. No povertymedicine.disease3. Good health030104 developmental biologyYears of potential life lostOncology030220 oncology & carcinogenesisbusinessearly diagnosisDemography
researchProduct

Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Este es el artículo que se ha publicado de forma definitiva en: https://molecularautism.biomedcentral.com/articles/10.1186/s13229-019-0262-8 En este artículo también participa Joan Climent, Vera Pancaldi, Lourdes Fañanás, Celso Arango, Mara Parellada, Anaïs Baudot, Daniel Vogt, John L. Rubenstein, Alfonso Valencia y Rafael Tabarés-Seisdedos. Background: Epidemiological and clinical evidence points to cancer as a comorbidity in people with autism spectrum disorders (ASD). A significant overlap of genes and biological processes between both diseases has also been reported. Methods: Here, for the first time, we compared the gene expression profiles of ASD frontal cortex tissues and 22 cancer t…

Autism.AutismComorbidityBioinformaticsAutismo.lcsh:RC346-429Expresión génica.TranscriptomeAfectividad - Trastornos.0302 clinical medicineNeoplasmsGene expression2.1 Biological and endogenous factorsAetiologyCàncerCáncer - Aspectos genéticos.ComputingMilieux_MISCELLANEOUSCancer0303 health sciencesProstate CancerBrainAffective disorders.3. Good healthPsychiatry and Mental healthMental HealthSignal transductionSignal TransductionBiotechnologyUrologic DiseasesIntellectual and Developmental Disabilities (IDD)1.1 Normal biological development and functioningClinical SciencesBiologyASDBiological pathway03 medical and health sciencesDevelopmental NeuroscienceUnderpinning researchmental disordersGeneticsmedicineHumansAutistic DisorderIntellectual and Developmental DisabilitiesGeneMolecular Biologylcsh:Neurology. Diseases of the nervous systemPI3K/AKT/mTOR pathwayCancer - Genetic aspects.030304 developmental biologyResearchNeurosciencesMultimorbidityCancermedicine.diseaseExpressió gènicaHuman geneticsBrain DisordersMeta-analysisGene expression.AutismGene expressionAutisme[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]TranscriptomeKidney cancer030217 neurology & neurosurgeryDevelopmental BiologyMolecular Autism
researchProduct

Additional file 3: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Definitions of specific cancer-site outcomes. (DOCX 27 kb)

3. Good health
researchProduct

Recensión bibliográfica

2013

Political sciencePublic Health Environmental and Occupational HealthGaceta Sanitaria
researchProduct

Additional file 2: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Key terms for PubMed/MEDLINE search. (DOCX 22 kb)

3. Good health
researchProduct

Additional file 2: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Key terms for PubMed/MEDLINE search. (DOCX 28 kb)

3. Good health
researchProduct

Clinical evidence from randomized trials, network meta-analyses, and conflicts of interests

2013

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryAlternative medicinelaw.inventionsurgical procedures operativeRandomized controlled trialNetwork Meta-AnalysesClinical evidencelawAntifibrinolytic agentcardiovascular systemmedicineSurgeryAprotinincardiovascular diseasesCardiology and Cardiovascular MedicineIntensive care medicinebusinessmedicine.drugThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Mejorar la transparencia y la credibilidad de los análisis coste-efectividad de las intervenciones sanitarias

2016

03 medical and health sciences0302 clinical medicine030503 health policy & servicesPolitical science030212 general & internal medicineGeneral Medicine0305 other medical scienceRevista Española de Salud Pública
researchProduct

Additional file 1: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

PRISMA-P Checklist. (DOCX 32 kb)

researchProduct

Additional file 3: of Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of…

2017

Definitions of specific cancer-site outcomes (DOCX 26 kb)

3. Good health
researchProduct

Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studies

2019

[Background] Autism spectrum disorder (ASD) is a complex developmental disorder characterised by impaired social interaction and communication, and restrictive and repetitive behaviour. Previous systematic reviews have traditionally assessed the prevalence of ASD on global or regional context, with very few meta-analyses at the country level. The objective of this study will be to systematically evaluate published and unpublished observational studies that present prevalence and comorbidity of ASD among children, adolescent and adult population in Spain.

GerontologyAdultAdolescentgenetic structuresEpidemiological studyAutism Spectrum DisorderPopulationMEDLINElcsh:MedicineMedicine (miscellaneous)PsycINFOComorbiditybehavioral disciplines and activities03 medical and health sciencesYoung Adult0302 clinical medicinemental disordersmedicineProtocolPrevalenceHumans030212 general & internal medicineAutism spectrum disordereducationChildeducation.field_of_studybusiness.industry030503 health policy & serviceslcsh:Rmedicine.diseaseComorbidity3. Good healthObservational Studies as TopicMeta-analysisSystematic reviewAutism spectrum disorderSpainMeta-analysisSystematic reviewObservational study0305 other medical sciencebusiness
researchProduct

Digital health interventions for children with ADHD

2020

Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder characterised by a persistent pattern of symptoms of inappropriate and impaired inattention, hyperactivity, or impulsivity, with difficulties often continuing into adulthood.1 It is estimated to affect 37·1 million children and young people (aged ≤20 years) worldwide.2 Although multiple ADHD treatments are available and widely used (eg, evidence-based behaviour therapy, medications, or a combination of both),3,4 their effectiveness has been questioned because they might not fully address the needs of many children with ADHD. Barriers to evidence-based treatment for ADHD include misconceptions and stigma, time, and…

medicine.medical_specialtybusiness.industryPsychological interventionMEDLINEMedicine (miscellaneous)Health InformaticsInterventionmedicine.diseaselcsh:Computer applications to medicine. Medical informaticsDigital healthAttention deficit hyperactivity disorderHealth Information ManagementAttention Deficit Disorder with HyperactivityIntervention (counseling)medicineAttention deficit hyperactivity disorderADHDlcsh:R858-859.7HumansDecision Sciences (miscellaneous)businessPsychiatryChildDigital health
researchProduct

MOESM2 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 2. Data extraction and normalisation processes.

TheoryofComputation_MATHEMATICALLOGICANDFORMALLANGUAGESComputingMethodologies_SYMBOLICANDALGEBRAICMANIPULATIONData_FILES3. Good health
researchProduct

MOESM3 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 3. Reporting checklist.

3. Good health
researchProduct

Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study

2011

Abstract Background and objective An important input to decision-making and health planning is a consistent and comparative description of the population health status. The purpose of this study was to describe the burden of disease in the Region of Valencia (Spain). Material and methods Disability-adjusted life years (DALYs) were calculated and divided into years of life lost (YLLs) and years lived with disability (YLDs). Using death registry data and Valencian population estimates in 2008, we calculated the number of deaths and YLLs. YLDs were based on age- and sex-specific data for countries of the EURO-A subregional level (which includes the Region of Valencia) from the Global Burden of…

AdultMaleBurden of diseaseAdolescentSense organHealth StatusPopulationPopulation healthValencianYoung AdultAge DistributionLife ExpectancyCost of IllnessCause of DeathHumansMedicineDisabled PersonsSex DistributionChildeducationDiagnosis-Related GroupsDisease burdenDepression (differential diagnoses)AgedAged 80 and overeducation.field_of_studybusiness.industryInfant NewbornInfantGeneral MedicineMiddle Agedlanguage.human_languageYears of potential life lostSpainChild PreschoolChronic DiseaselanguageFemalebusinessDemographyMedicina Clínica
researchProduct

Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis

2018

[Background]: The management of comorbidity and multimorbidity poses major challenges to health services around the world. Analysis of scientific research in comorbidity and multimorbidity is limited in the biomedical literature. This study aimed to map global scientific research in comorbidity and multimorbidity to understand the maturity and growth of the area during the past decades. [Methods and findings]: This was a cross-sectional analysis of the Web of Science. Searches were run from inception until November 8, 2016. We included research articles or reviews with no restrictions by language or publication date. Data abstraction was done by one researcher. A process of standardization …

Cross-sectional studylcsh:MedicineComorbidity030204 cardiovascular system & hematologyGeographical locations0302 clinical medicineEndocrinologyCitation analysisMedicine and Health Sciences030212 general & internal medicinelcsh:ScienceGeriatricsMultidisciplinaryDepressionHealth services researchResearch AssessmentPatologia3. Good healthCitation AnalysisHealth Services ResearchPsychologyResearch Articlemedicine.medical_specialtyEndocrine DisordersSpecialtyMEDLINEImpacteResearch and Analysis Methods03 medical and health sciencesBibliometriamental disordersMental Health and PsychiatrymedicineDiabetes MellitusHumansMood DisordersResearchlcsh:Rmedicine.diseaseComorbidityUnited StatesHealth CareCross-Sectional StudiesGeriatricsFamily medicineNational Comorbidity SurveyMetabolic DisordersNorth Americalcsh:QPeople and placesPLoS ONE
researchProduct

Additional file 1: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Table S1. Datasets included in our study. Table S2. Age, gender and pmi distributions between cases and control samples at each step of the preprocessing procedure at the asd defferentail gene expression meta-analysis. Table S3. Final samples included in the asd meta-analysis. Table S4. Jointly same direction derregulated genes in asd ans sddcs and jointly oposite direction derregulated genes in asd and oddcs. Table S5. Genes jointly deregulated in asd and in sddcs and oddcs. Figure S1. Comaprison of differential gene expression analysis using limma with rlog transformed data and two state of the art rnaseq differential expression metdos. Figure S2. Patient overlap in the three asd studies.…

mental disorders
researchProduct

Additional file 2: of Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic revi…

2019

Key terms for PubMed/MEDLINE search. (DOCX 29 kb)

researchProduct

PCV28 Control of Hypertension in Spain: A Systematic Review and Meta-Analysis of 76 Epidemiological Studies on 341,632 Participants

2011

medicine.medical_specialtybusiness.industryHealth PolicyEnvironmental healthMeta-analysisEpidemiologyPublic Health Environmental and Occupational HealthmedicinebusinessValue in Health
researchProduct

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study …

2020

Publisher's version (útgefin grein)

MaleLife expectancyDisability-Adjusted Life YearDiseasesDiseasecommunicable diseasesystematic analysisGlobal Burden of Disease0302 clinical medicine80 and overMedicine10. No inequalityChild11 Medical and Health SciencesinjuriesAged 80 and overeducation.field_of_studySjúkdómarDEMENTIAFALLSGeneral MedicineForvarnir3. Good healthChild PreschoolHumanGBDPopulation health03 medical and health sciencesSDG 3 - Good Health and Well-beingHumansGlobal Burden of Disease StudyeducationAgedSpatial AnalysisGlobal burdenDisabilityPreventionDISABILITYInfantSpatial AnalysiMortality rateGlobal Burden of Disease Diseases Injuries Systematic analysisPREVENTIONYears of potential life lostRisk factorsDisease studyGBD; communicable disease; injuries;ITC-ISI-JOURNAL-ARTICLELife expectancyRISK-FACTORSClinical MedicineRADemographyFötlunDánartíðniÁhættuþættir030204 cardiovascular system & hematologyRisk FactorsCause of DeathGlobal health030212 general & internal medicineMortality ratePopulation health1. No povertyDisability-Adjusted Life YearsPublic Health Global Health Social Medicine and EpidemiologyMiddle Aged3142 Public health care science environmental and occupational healthAdolescent; Adult; Age Distribution; Aged; Aged 80 and over; Cause of Death; Child; Child Preschool; Disability-Adjusted Life Years; Female; Global Burden of Disease; Humans; Infant; Infant Newborn; Male; Middle Aged; Risk Factors; Spatial Analysis; Young Adult/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLýðheilsaFemaleCLINICAL-TRIALSAdultAdolescentPopulationGlobal healthSettore MED/01 - Statistica MedicadiseasesITC-HYBRIDYoung AdultHeilbrigðisvísindiAge DistributionGeneral & Internal MedicineMortalityPreschoolDisease burdenbusiness.industryRisk FactorKlinisk medicinInfant NewbornNewborn//purl.org/pe-repo/ocde/ford#3.02.00 [https]Folkhälsovetenskap global hälsa socialmedicin och epidemiologiÁverkarSystematic analysisNAbusiness
researchProduct

Global injury morbidity and mortality from 1990 to 2017 : results from the Global Burden of Disease Study 2017

2020

Publisher's version (útgefin grein)

DánarmeinFötlunDánartíðniLífslíkurLife expectancy1106 Human Movement and Sports Sciencesburden of diseaseGlobal HealthGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal healthMedicineLIFE EXPECTANCY030212 general & internal medicine1506POPULATIONCause of deathOriginal ResearchRISKeducation.field_of_studyGlobal disease burdensInjuriesSjúkdómarIncidence (epidemiology)IncidencePopulation healthBurden of diseaseGlobalglobal3142 Public health care science environmental and occupational health3. Good healthDescriptive epidemiologyLýðheilsaQuality-Adjusted Life YearsPublic HealthTERRITORIESdescriptive epidemiologyHumanPopulation195 COUNTRIESPopulation healthCause of deathburden of disease; descriptive epidemiology; global; Humans; Incidence; Life Expectancy; Morbidity; Quality-Adjusted Life Years; Global Burden of Disease; Global Health; Wounds and Injuries1117 Public Health and Health Services03 medical and health sciencesAGESYSTEMATIC ANALYSISHumansMortalityeducationDisabilitySEX-SPECIFIC MORTALITYbusiness.industryFaraldsfræðiDISABILITYPublic Health Environmental and Occupational HealthQuality-adjusted life yearYears of potential life lostÁverkar1701 PsychologyLife expectancyWounds and InjuriesHuman medicineMorbiditybusiness030217 neurology & neurosurgeryDemography
researchProduct

Control of arterial hypertension in Spain

2011

Hypertension is a leading global risk factor for the burden of cardiovascular disease. Data about changes in hypertension control are important to set intervention priorities. We conducted a systematic review and meta-analysis of epidemiological studies to determine the control of hypertension in Spain over the past decade.A search of PubMed/MEDLINE, SCOPUS and IME was performed for epidemiological studies conducted in Spain (since 2000) with data on control rates for hypertension. The primary outcome was the prevalence of uncontrolled hypertension defined as the percentage of patients having SBP at least 140 mmHg and/or DBP at least 90 mmHg. For populations at risk (e.g. patients with diab…

medicine.medical_specialtyHypertension controlPhysiologybusiness.industryMEDLINEDiseaseRisk FactorsSpainMeta-analysisHypertensionEpidemiologyPrevalenceInternal MedicinemedicinePhysical therapyHumansCardiology and Cardiovascular MedicineIntensive care medicinebusinessGlobal riskJournal of Hypertension
researchProduct

The Global Research Collaboration of Network Meta-Analysis: A Social Network Analysis

2016

et al.

Comparative Effectiveness ResearchSocial Scienceslcsh:MedicineCochrane LibraryGeographical locationsMathematical and Statistical Techniques0302 clinical medicineSociologyMedicine and Health SciencesCentrality030212 general & internal medicineHealth Systems Strengtheninglcsh:ScienceSocial network analysisMultidisciplinaryResearch Assessment3. Good healthProfessionsSystematic reviewSocial NetworksResearch Design030220 oncology & carcinogenesisMeta-analysisPhysical SciencesNetwork AnalysisStatistics (Mathematics)Research ArticleComputer and Information SciencesCanadaSystematic ReviewsClinical Research DesignMEDLINELibrary scienceResearch and Analysis Methods03 medical and health sciencesPolitical scienceStatistical MethodsChinaProductivityHealth Care Policylcsh:RHealth CareRankingPeople and PlacesNorth AmericaScientistsPopulation Groupingslcsh:QMathematicsMeta-AnalysisPLOS ONE
researchProduct

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015 : a systematic analysi…

2016

BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 Study (GBD 2015) provides an analytical framework to comprehensively assess these trends for under-5 mortality, age-specific and cause-specific mortality among children under 5 years, and stillbirths by geography over time. METHODS: Drawing from ana…

PediatricsNutrition and DiseaseGlobal HealthCommunicable Disease0302 clinical medicineVoeding en ZiekteInfant MortalityCompensation law of mortalityGlobal healthMedicineLIFE EXPECTANCY030212 general & internal medicineDEVELOPING-COUNTRIES10. No inequalityMedicine(all)NEWBORN BABIESMedicine (all)Mortality rate1. No povertyDEATHPublic Health Global Health Social Medicine and EpidemiologyGeneral Medicine11 Medical And Health SciencesStillbirth3. Good healthChild MortalitySURVIVALCHILD-MORTALITYHEALTHLife Sciences & BiomedicineDEVELOPMENT GOAL 4HumanINTERVENTIONSmedicine.medical_specialtyRJINTEGRATED APPROACHDeveloping country610Communicable Diseasesneonatal03 medical and health sciencesMedicine General & Internal030225 pediatricsGeneral & Internal MedicineLife ScienceHumansGlobal Burden of Disease StudyVLAGEstimationScience & Technologybusiness.industryKlinisk medicinInfantGBD 2015 Child Mortality CollaboratorsInfant mortalityMalariaChild mortalityFolkhälsovetenskap global hälsa socialmedicin och epidemiologiLife expectancyClinical MedicineRGbusinessDemography
researchProduct

Additional file 1: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

PRISMA-P Checklist. (DOCX 27 kb)

3. Good health
researchProduct

Global collaborative networks on meta-analyses of randomized trials published in high impact factor medical journals: a social network analysis

2014

Abstract Background Research collaboration contributes to the advancement of knowledge by exploiting the results of scientific efforts more efficiently, but the global patterns of collaboration on meta-analysis are unknown. The purpose of this research was to describe and characterize the global collaborative patterns in meta-analyses of randomized trials published in high impact factor medical journals over the past three decades. Methods This was a cross-sectional, social network analysis. We searched PubMed for relevant meta-analyses of randomized trials published up to December 2012. We selected meta-analyses (including at least randomized trials as primary evidence source) published in…

Evidence-based medicineMEDLINELibrary science030204 cardiovascular system & hematologyGlobal HealthSocial Networkinglaw.inventionSocial network analysis03 medical and health sciences0302 clinical medicineMeta-Analysis as TopicRandomized controlled triallawGlobal healthHumansMedicine030212 general & internal medicineCooperative BehaviorMeta-Analysis as TopicRandomized Controlled Trials as TopicMedicine(all)business.industryClinical study designGeneral MedicineEvidence-based medicineAuthorship3. Good healthMeta-analysisCross-Sectional StudiesScientific collaborationRandomized controlled trialMeta-analysisJournal Impact FactorbusinessCitationResearch ArticleBMC Medicine
researchProduct

Additional file 1: of Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic revi…

2019

PRISMA-P Checklist. (DOCX 33 kb)

researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systema…

2015

[Background] Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of children and adolescents, with a significant impact on health services and the community in terms of economic and social burdens. The objective of this systematic review will be to evaluate the comparative efficacy and safety of pharmacological and non-pharmacological treatments in children and adolescents with ADHD.

Complementary Therapiesmedicine.medical_specialtyAdolescentPsychological interventionMEDLINEMedicine (miscellaneous)law.inventionAttention deficit hyperactivity disorder03 medical and health sciences0302 clinical medicineClinical ProtocolsRandomized controlled trialCognició en els infantsBehavior Therapylawmental disordersOutcome Assessment Health CareProtocolHumansADHDMedicineAttention deficit hyperactivity disorder030212 general & internal medicineChildPsychiatryChildrenInfants hiperactiusbusiness.industrymedicine.diseaseChiropractic3. Good healthTreatmentClinical trialMeta-analysisSystematic reviewAttention Deficit Disorder with HyperactivityResearch DesignMeta-analysisSystematic reviewbusiness030217 neurology & neurosurgeryCentral Nervous System AgentsSystematic Reviews as TopicSystematic Reviews
researchProduct

Additional file 2: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

Key terms for PubMed/MEDLINE search. (DOCX 20 kb)

3. Good health
researchProduct

Additional file 1: of The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review

2016

Reporting methods and results of CEA Spain_annex. Table S1. PubMed/MEDLINE search strategy. Table S2. Included studies. Table S3. PRISMA Checklist. Figure S1. Flow diagram for study selection. Figure S2. Growth in published cost-effectiveness analyses. Spain, 1989-2014.

researchProduct

MOESM6 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 6. Exploratory analysis of topical data.

Data_FILES3. Good health
researchProduct

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

2020

INTRODUCTION: There has been a growing awareness of the need for rigorously and transparent reported health research, to ensure the reproducibility of studies by future researchers. Health economic evaluations, the comparative analysis of alternative interventions in terms of their costs and consequences, have been promoted as an important tool to inform decision-making. The objective of this study will be to investigate the extent to which articles of economic evaluations of healthcare interventions indexed in MEDLINE incorporate research practices that promote transparency, openness and reproducibility. METHODS AND ANALYSIS: This is the study protocol for a cross-sectional comparative ana…

Cost-Benefit Analysisdata sharingMEDLINEcost-effectiveness analysis data sharing methodology quality reporting reproducibility03 medical and health sciencesHealth Economics0302 clinical medicineHealth careProtocolOpenness to experienceHumansMedicine17011506030212 general & internal medicinereproducibilityProtocol (science)reportingMedical educationbusiness.industry030503 health policy & servicesCost-effectiveness analysiscost-effectiveness analysisRMethodologyReproducibility of ResultsmethodologyGeneral MedicineCost-effectiveness analysisTransparency (behavior)QualityReproducibility3. Good healthEconomics MedicalData sharingCross-Sectional StudiesReportingResearch DesignqualityEconomic evaluationMedicineData sharingQuality-Adjusted Life Years0305 other medical sciencebusiness
researchProduct

Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

2023

Background The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led to these gaps is the issue of the financing of national health systems, especially in low-income and middle-income countries (LMICs), as well as a robust global system for pandemic preparedness. We aimed to provide a comparative assessment of global health spending at the onset of the pandemic; characterise the amount of development assistance for pandemic preparedness and response disbursed in the first 2 years of the COVID-19 pandemic; and examine expectations for future health spending and put into context the expected ne…

coordinationcommunicationoutbreak responseCOVID-19 GBDresponse planPublic Health Global Health Social Medicine and EpidemiologyGeneral Medicinecontact managementpandemic Covid 19financingepidemic alertepidemiological investigationFolkhälsovetenskap global hälsa socialmedicin och epidemiologiinternational health regulationsurveillanceGlobal burden diseasefinancing; global spending; pandemic Covid 19;global spendingpreparedne
researchProduct

MOESM5 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 5. List of excluded articles.

Data_FILESTheoryofComputation_GENERALGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countr…

2015

Summary Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age–sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic develo…

GerontologyMaleCHANGING RELATIONNutrition and DiseaseMESH : Life ExpectancyMESH : AgedECONOMIC-DEVELOPMENTPoison controlMESH: Global HealthGlobal HealthSocioeconomic FactorCommunicable DiseaseMESH : Chronic DiseaseHealth TransitionVoeding en ZiekteQuality-Adjusted Life YearSELF-RATED HEALTHMESH : Socioeconomic FactorsMedicineMESH : FemaleMESH: Mortality Premature2. Zero hungerMESH: Agededucation.field_of_studyMESH: Middle AgedMortality rateMedicine (all)GBD2013 diseases[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieGeneral MedicineMiddle Aged3. Good healthMESH : Wounds and InjuriesEpidemiological transitionMESH: Quality-Adjusted Life YearsMESH: Communicable DiseasesNONCOMMUNICABLE DISEASESFemaleQuality-Adjusted Life YearsMESH: Life ExpectancyMESH: Health TransitionHumanMESH: Socioeconomic FactorsACUTE MYOCARDIAL-INFARCTIONMESH : MaleMORTALITY TRENDSPopulationMESH : Health TransitionCommunicable DiseasesArticleLife ExpectancyEUROPEAN-UNIONSDG 3 - Good Health and Well-beingGeneral & Internal MedicineSYSTEMATIC ANALYSISDisability-adjusted life yearHumansLife ScienceMESH : Middle AgedMortalityeducationPrematureMESH : Mortality PrematureVLAGAgedMESH: Humansbusiness.industryMortality PrematureMESH: Chronic DiseaseMESH : Communicable DiseasesWounds and InjurieMESH : HumansMESH : Quality-Adjusted Life YearsNon-communicable diseaseAged; Chronic Disease; Communicable Diseases; Female; Global Health; Humans; Male; Middle Aged; Mortality Premature; Quality-Adjusted Life Years; Socioeconomic Factors; Wounds and Injuries; Health Transition; Life Expectancy; Medicine (all)medicine.diseaseMESH: MaleLOW SOCIOECONOMIC-STATUSYears of potential life lostSocioeconomic Factors[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieMESH: Wounds and InjuriesChronic DiseaseLife expectancyRISK-FACTORSMESH : Global HealthWounds and Injuries[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessMESH: FemaleDemographyLancet
researchProduct

The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013.

2017

The Eastern Mediterranean Region (EMR) is witnessing an increase in chronic disorders, including mental illness. With ongoing unrest, this is expected to rise. This is the first study to quantify the burden of mental disorders in the EMR. We used data from the Global Burden of Disease study (GBD) 2013. DALYs (disability-adjusted life years) allow assessment of both premature mortality (years of life lost-YLLs) and nonfatal outcomes (years lived with disability-YLDs). DALYs are computed by adding YLLs and YLDs for each age-sex-country group. In 2013, mental disorders contributed to 5.6% of the total disease burden in the EMR (1894 DALYS/100,000 population): 2519 DALYS/100,000 (2590/100,000 m…

MaleGerontologyTime FactorsL900Health Statuslcsh:MedicineGlobal HealthGeographical Locations0302 clinical medicineMedicine and Health SciencesGlobal healthPublic and Occupational Health030212 general & internal medicineChildlcsh:ScienceDepression (differential diagnoses)Aged 80 and overeducation.field_of_studyPublic healthMultidisciplinaryMediterranean RegionDepressionMental DisordersAge FactorsMiddle AgedAnxiety DisordersSocioeconomic Aspects of HealthMental illnessChild PreschoolMediterrània orientalAnxietyFemaleEgyptmedicine.symptomResearch ArticleAdultAdolescentEastern MediterraneanPopulationNeuropsychiatric DisordersNeurosesYoung Adult03 medical and health sciencesLife ExpectancySex FactorsMental Health and PsychiatrymedicineHumanseducationDisease burdenAgedMood Disordersbusiness.industrylcsh:RInfant NewbornInfantMental illnessmedicine.diseaseMental healthSalut pública030227 psychiatryHealth CareB900Age GroupsPeople and PlacesAfricaLife expectancyRC0321Population Groupingslcsh:QbusinessMalalties mentalsDemography
researchProduct

Promotion of public access and share of raw data from scientific research

2015

Editorial. Plan Nacional de I + D + i, 2012, del Ministerio de Economía y Competitividad. Fundación Mapfre, convocatoria 2012. Peer Reviewed

business.industryMedicineGeneral MedicinebusinessHumanities
researchProduct

MOESM2 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 2. Data extraction and normalisation processes.

TheoryofComputation_MATHEMATICALLOGICANDFORMALLANGUAGESComputingMethodologies_SYMBOLICANDALGEBRAICMANIPULATIONData_FILES3. Good health
researchProduct

Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

BACKGROUND: Anorexia nervosa is characterized by a severe restriction of caloric intake, low body weight, fear of gaining weight or of becoming fat, and disturbance of body image. Pathogenesis of the disorder may include genetic predisposition, hormonal changes and a combination of environmental, psychosocial, and cultural factors. Cancer is the second leading cause of death worldwide. At present, no systematic reviews and meta-analyses have evaluated the risk of cancer in people with anorexia nervosa. The objective of this study will be to evaluate the association between anorexia nervosa and the risk of developing or dying from cancer. METHODS/DESIGN: This study protocol is part of a syst…

medicine.medical_specialtyAnorexia NervosaEpidemiological studyMedicine (miscellaneous)lcsh:Medicine03 medical and health sciences0302 clinical medicineNeoplasmsEpidemiologymental disordersmedicineProtocolHumans030212 general & internal medicinePsychiatryCancerbusiness.industryIncidencelcsh:REating disorderCancerCáncermedicine.disease3. Good healthMeta-analysisSystematic reviewAnorexia nervosa (differential diagnoses)030220 oncology & carcinogenesisMeta-analysisCohortSystematic reviewbibliometríaObservational studybusinessPsychosocialanorexia nerviosaSystematic Reviews as Topic
researchProduct

MOESM1 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 1. Full strategy in PubMed/MEDLINE.

3. Good health
researchProduct

Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis

2012

BackgroundCost-Effectiveness Analysis (CEA) has been promoted as an important research methodology for determining the efficiency of healthcare technology and guiding medical decision-making. Our aim was to characterize the collaborative patterns of CEA conducted over the past two decades in Spain.Methods and findingsA systematic analysis was carried out with the information obtained through an updated comprehensive literature review and from reports of health technology assessment agencies. We identified CEAs with outcomes expressed as a time-based summary measure of population health (e.g. quality-adjusted life-years or disability-adjusted life-years), conducted in Spain and published bet…

Knowledge managementNon-Clinical MedicineCost effectivenessScience PolicyEconomicsPolitical ScienceCost-Benefit AnalysisSciencePublic PolicyBibliometricsTechnology assessmentSocial and Behavioral SciencesInvestigacióHealth EconomicsSociologyMedicineCooperative BehaviorHealth Systems StrengtheningMultidisciplinaryHealth economicsHealth Care PolicyCost–benefit analysisbusiness.industryQHealth services researchRHealth technologyCost-effectiveness analysisResearch AssessmentAuthorshipSocial NetworksBibliometricsMedicinebusinessResearch Article
researchProduct

Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2016

BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015.METHODS: We estimated maternal mortality at the global, regional, and national levels from 1990 to 2015 for ages 10-54 years by systematically compiling and processing all available data sources from 186 of 195 countries and territories, 11 of which were analysed at the subnational level. We quantified eight underl…

0301 basic medicinePediatricsNutrition and DiseaseMILLENNIUM DEVELOPMENT GOALSSUSTAINABLE DEVELOPMENT GOALSANTENATAL CAREGlobal Health0302 clinical medicineVoeding en Ziekte11. SustainabilityGlobal healthHQHealthcare FinancingEMERGENCY OBSTETRIC CARE030212 general & internal medicineCooperative Behavior10. No inequalityReproductive healthMedicine(all)education.field_of_study030219 obstetrics & reproductive medicineMedicine (all)1. No povertyObstetrics and GynecologyPublic Health Global Health Social Medicine and EpidemiologyPrenatal CareGeneral Medicine11 Medical And Health SciencesLOW-RESOURCE SETTINGS3142 Public health care science environmental and occupational healthFamily Planning Service3. Good healthGBD 2015 Maternal Mortality CollaboratorsGovernment ProgramsMaternal MortalityReproductive HealthFamily Planning ServicesMaternal deathHEALTHLife Sciences & BiomedicineHumanCOUNTRIESmedicine.medical_specialtyPopulation610Prenatal careArticle03 medical and health sciencesMedicine General & InternalSDG 3 - Good Health and Well-beingCASH TRANSFER PROGRAMEnvironmental healthGeneral & Internal Medicineparasitic diseasesmedicineLife ScienceQUALITYHumansGlobal Burden of Disease StudyeducationVLAGScience & TechnologyMedical Assistancebusiness.industryKlinisk medicinParturitionObstetric transitionmedicine.diseaseQPInfant mortalityFolkhälsovetenskap global hälsa socialmedicin och epidemiologiStandardized mortality ratio030104 developmental biologyRISK-FACTORSRGClinical MedicinebusinessRA
researchProduct

MOESM1 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 1. Full strategy in PubMed/MEDLINE.

3. Good health
researchProduct

PCV71 Sponsorship and Pharmacoeconomic Conclusions of Studies on Statin Use for Cardiovascular Prevention: A Systematic Analysis

2011

medicine.medical_specialtyCardiovascular preventionbusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthmedicineAlternative medicineStatin treatmentIntensive care medicinebusinessValue in Health
researchProduct

Additional file 1: of Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of…

2017

PRISMA-P Checklist (DOCX 27 kb)

3. Good health
researchProduct

Additional file 1: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

PRISMA-P checklist. (DOCX 24 kb)

3. Good health
researchProduct

MOESM4 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 4. List of PMID for included articles.

Data_FILESGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

Evaluación del efecto de los tratamientos utilizando comparaciones indirectas

2013

business.industryMedicineCardiology and Cardiovascular MedicinebusinessHumanitiesRevista Española de Cardiología
researchProduct

Additional file 2: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Key terms for PubMed/MEDLINE search. (DOCX 22 kb)

3. Good health
researchProduct

Síntesis de la evidencia clínica y metaanálisis en red con comparaciones indirectas

2013

business.industryMedicineGeneral MedicinebusinessHumanitiesMedicina Clínica
researchProduct

Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-d…

2017

BACKGROUND: Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are childhood onset neurodevelopmental disorders that may persist into adulthood. ASD and ADHD tend to run in families and may have a significant negative impact on the health and longevity of those with the disorder and their relatives. The aim of this study will be to analyze the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. METHODS/DESIGN: We will conduct a systematic review and meta-analysis of observational studies. Searches of PubMed/MEDLINE, EMBASE, PsycINFO, SCOPUS, and ISI Web of Science will be used to identify epidemiologica…

Research designMaleEpidemiologyAutism Spectrum DisorderMedicine (miscellaneous)lcsh:MedicineTrastorns de l'atencióAdolescents0302 clinical medicineCause of DeathRisk of mortalityProtocol030212 general & internal medicineChildChild developmentNeurodevelopmental disordersAutism spectrum disorders3. Good healthAutism spectrum disorderResearch DesignMeta-analysisFemaleInfantsCohort studyAdultRiskmedicine.medical_specialtyAdolescentAttention deficit hyperactivity disorder03 medical and health sciencesBibliometriamental disordersmedicineMortalitatAttention deficit hyperactivity disorderAdultsHumansFamilyFirst-degree relativesMortalityPsychiatrybusiness.industrylcsh:Rmedicine.diseaseMeta-analysisAttention Deficit Disorder with HyperactivitySystematic reviewObservational studyAutismebusiness030217 neurology & neurosurgerySystematic Reviews as Topic
researchProduct

Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Devel…

2020

BACKGROUND: Sustainable Development Goal (SDG) 3 aims to "ensure healthy lives and promote well-being for all at all ages". While a substantial effort has been made to quantify progress towards SDG3, less research has focused on tracking spending towards this goal. We used spending estimates to measure progress in financing the priority areas of SDG3, examine the association between outcomes and financing, and identify where resource gains are most needed to achieve the SDG3 indicators for which data are available. METHODS: We estimated domestic health spending, disaggregated by source (government, out-of-pocket, and prepaid private) from 1995 to 2017 for 195 countries and territories. For …

Economic growthFinancing GovernmentPsychological interventionHIV Infectionsburden of disease030204 cardiovascular system & hematologyDISEASEALLOCATION0302 clinical medicineRA0421RA0421 Public health. Hygiene. Preventive MedicineSustainable developmentGlobal healthhealth economicsHealthcare FinancingHIV Infection030212 general & internal medicine10. No inequality11 Medical and Health SciencesDALYHealthy lives1. No povertyPublic Health Global Health Social Medicine and Epidemiology3rd-DASGeneral MedicineSustainable Development3. Good healthtuberculosisIMPOVERISHMENTTERRITORIESFinancingHumanFinancing PersonalResource (biology)Tuberculosi195 COUNTRIESDeveloping Countrie03 medical and health sciencesSDG 3 - Good Health and Well-beingAcquired immunodeficiency syndrome (AIDS)General & Internal MedicineSYSTEMATIC ANALYSISmedicineHumansBurden HIV/AIDS tubercolosis malariaHuman resourcesDeveloping CountriesSustainable developmentGovernmentAcquired Immunodeficiency SyndromeHealth economicsbusiness.industryDISABILITYCATASTROPHEGlobal Burden of Disease Health Financing Collaborator NetworkGLOBAL BURDENmedicine.diseaseMalariaSDG; health sector spending; development assistant for health.Health ExpenditureFolkhälsovetenskap global hälsa socialmedicin och epidemiologi3121 General medicine internal medicine and other clinical medicineNAHealth ExpendituresbusinessEXPENDITURE
researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review wi…

2017

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. Methods and findings We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacolo…

Complementary TherapiesMaleTrastorns de l'atencióPoison controllcsh:MedicineMathematical and Statistical Techniques0302 clinical medicineBehavior TherapyMedicine and Health SciencesMedicine030212 general & internal medicineChildlcsh:ScienceRandomized Controlled Trials as TopicMultidisciplinaryPharmaceuticsMethylphenidate3. Good healthGuanfacineAntidepressant Drug TherapyNeurologyTolerabilityBehavioral PharmacologyResearch DesignPhysical SciencesFemaleStatistics (Mathematics)Research Articlemedicine.drugNeurological Drug Therapymedicine.medical_specialtyAdolescentClinical Research DesignNeuropsychiatric DisordersResearch and Analysis MethodsPlacebo03 medical and health sciencesDevelopmental NeuroscienceDrug TherapyInternal medicineMental Health and PsychiatryHumansAttention deficit hyperactivity disorderPsiquiatriaStatistical MethodsAdverse effectPsychiatryPharmacologyBehaviorbusiness.industryAtomoxetinelcsh:RCentral Nervous System DepressantsBiology and Life Sciencesmedicine.diseaseAttention Deficit Disorder with HyperactivityNeurodevelopmental DisordersCentral Nervous System StimulantsAdhdlcsh:QAdverse EventsbusinessMental Health TherapiesMathematics030217 neurology & neurosurgeryNeuroscienceMeta-AnalysisPLoS ONE
researchProduct

Evaluation of Comparative Treatment Effects Using Indirect Comparisons

2013

medicine.medical_specialtybusiness.industrymedicineMedical physicsGeneral MedicinebusinessRevista Española de Cardiología (English Edition)
researchProduct

Additional file 1: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

PRISMA-P Checklist. (DOCX 27 kb)

3. Good health
researchProduct

Additional file 2: of Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of…

2017

Key terms for PubMed/MEDLINE search (DOCX 22 kb)

3. Good health
researchProduct

PIH47 Measuring the Burden of Disease and Injury in Spain Using Disability-Adjusted Life Years: A Population-Based Study

2011

Population based studyBurden of diseaseGerontologyYears of potential life lostbusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthMedicinebusinessValue in Health
researchProduct

Additional file 3: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Methodological Quality Checklist for Prevalence data. (DOCX 28 kb)

3. Good health
researchProduct

MOESM6 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 6. Exploratory analysis of topical data.

Data_FILES3. Good health
researchProduct

Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies

2017

[Background] The objective of this study will be to synthesize the epidemiological evidence and evaluate the validity of the associations between central nervous system disorders and the risk of developing or dying from cancer.

Research designAnorexia NervosaBipolar DisorderMedicine (miscellaneous)lcsh:MedicineDisease0302 clinical medicineDown’s syndromeCentral Nervous System DiseasesNeoplasmsProtocolMedicine030212 general & internal medicineCàncerCancerDepressionIncidenceHuntington’sdiseaseAnorèxia nerviosaAutism spectrum disorders3. Good healthObservational Studies as TopicSystematic reviewResearch DesignMeta-analysisEsquizofrèniaAlzheimer’s diseaseHuntington’s diseasemedicine.medical_specialtyCentral nervous system disorderMultiple SclerosisBipolar disorderSistema nerviós central MalaltiesMEDLINEMultiple sclerosisParkinson’s Disease03 medical and health sciencesMeta-Analysis as TopicDown’s SyndromeHuntington’s DiseaseHumansAlzheimer’s DiseasePsychiatryIntensive care medicineEpilepsybusiness.industrylcsh:RAmyotrophic Lateral SclerosisCancerCentral Nervous System DisorderAnorexia nervosamedicine.diseaseAmyotrophic lateral sclerosisMeta-analysisReview Literature as TopicParkinson’s diseaseSystematic reviewSchizophreniaObservational Studies as TopicObservational studySystematic ReviewAutismebusiness030217 neurology & neurosurgerySystematic Reviews as TopicMeta-Analysis
researchProduct

The increasing burden of mental and neurological disorders.

2013

Pharmacologymedicine.medical_specialtybusiness.industryMental DisordersMEDLINEPsychiatry and Mental healthText miningNeurologyCost of IllnessmedicineCost of illnessHumansPharmacology (medical)Neurology (clinical)Nervous System DiseasesbusinessIntensive care medicineBiological PsychiatryEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controll…

2015

Severe gastroenteritis caused by canine parvovirus type 2 (CPV2) is a serious life-threatening disease in puppies less than 4-months of age. The emergence of new variants has provoked some concern about the cross-protection elicited by licensed canine parvovirus modified-live type 2 (CPV2) and type 2b (CPV2b) vaccines against the most recent subtype CPV2c. A systematic review was carried out to assess the efficacy of commercial vaccines. We conducted a literature search of Pub Med/MEDLINE from January 1990 to May 2014. This was supplemented by hand-searching of related citations and searches in Google/Google Scholar. Controlled clinical trials in which vaccinated puppies were challenged wit…

medicine.medical_specialtyBlindingParvovirus CanineCross ProtectionDiseaseMicrobiologyParvoviridae InfectionsDogsSpecies SpecificityInternal medicineAnimalsMedicineDog DiseasesViral sheddingGeneral Veterinarybiologybusiness.industryViral VaccineCanine parvovirusViral VaccinesGeneral Medicinebiology.organism_classificationVaccine efficacyGastroenteritisVirus SheddingClinical trialSystematic reviewImmunologybusinessVeterinary Microbiology
researchProduct

Revisión de las evaluaciones económicas de intervenciones en enfermedades cardiovasculares en España

2012

PharmacologyFarmacia Hospitalaria
researchProduct

The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review

2016

Open Access; Open Peer Review.-- et al.

Research designCost effectivenessCost-Benefit AnalysisMEDLINEMedicine (miscellaneous)030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineCentre for Reviews and DisseminationEnvironmental healthHumansMedicineQuality-adjusted life years030212 general & internal medicineProtocol (science)Cost–utility analysisbusiness.industryResearchCost-effectiveness analysisCost-utility analysisMethodologyCost-effectiveness analysis3. Good healthQuality-adjusted life yearReportingResearch DesignSpainbusinessDelivery of Health CareSystematic Reviews
researchProduct

Safety of aprotinin in adult cardiac surgery: revisiting the validity of a mixed-treatment comparison meta-analysis.

2013

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryTreatment comparisonBlood Loss SurgicalPostoperative HemorrhageAntifibrinolytic AgentsCardiac surgeryAprotininMeta-analysisAnesthesiaAntifibrinolytic agentmedicineHumansSurgeryAprotininCardiology and Cardiovascular MedicinebusinessIntensive care medicinemedicine.drugThe Journal of thoracic and cardiovascular surgery
researchProduct

Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

[Background]: Randomised controlled trials (RCTs) provide the most reliable information to inform clinical practice and patient care. We aimed to map global clinical research publication activity through RCT-related articles in high-impact-factor medical journals over the past five decades.

medicine.medical_specialtyEvidence-based medicineCross-sectional studyHigh impact factorMEDLINEMedicine (miscellaneous)030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineHumansPharmacology (medical)030212 general & internal medicineRandomized Controlled Trials as Topiclcsh:R5-920business.industryResearchPublicationsEvidence-based medicinehumanities3. Good healthCross-Sectional StudiesClinical researchScientific collaborationPublishingRandomized controlled trialFamily medicineJournal Impact FactorPeriodicals as TopicbusinessCitationlcsh:Medicine (General)
researchProduct

Global health priorities and research funding

2013

Economic growthBiomedical ResearchInfectious DiseasesPolitical scienceGlobal healthHumansCommunicable DiseasesResource AllocationThe Lancet Infectious Diseases
researchProduct

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for …

2015

Background Up-to-date evidence on levels and trends for age-sex-specific all-cause and cause-specific mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries. Methods We estimated age-sex-specific all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included…

MaleAgingPediatricsNutrition and DiseaseDatabases FactualDisease030204 cardiovascular system & hematologyGlobal HealthMedical and Health SciencesDOUBLE-BLIND0302 clinical medicineAdolescent; Adult; Aged; Aged 80 and over; Cause of Death; Child; Child Mortality; Child Preschool; Databases Factual; Female; Global Health; Humans; Infant; Infant Newborn; Life Expectancy; Life Tables; Male; Middle Aged; Models Statistical; Mortality; Sex Distribution; Young AdultModelsVoeding en ZiekteCause of DeathEpidemiologyGlobal health80 and over2.2 Factors relating to the physical environmentLife Tables030212 general & internal medicineAetiologyChildINFLUENZAE TYPE-B11 Medical and Health SciencesCause of deathPediatricAged 80 and overPLACEBO-CONTROLLED-TRIALLife TableMortality rateMedicine (all)1. No povertyGeneral MedicineCHILDHOOD PNEUMONIAMiddle AgedStatistical3. Good healthInfectious DiseasesChild PreschoolPNEUMOCOCCAL CONJUGATE VACCINEChild MortalityFemaleInfectionLife Sciences & BiomedicineHumanAdultmedicine.medical_specialtyAdolescentINTEGRATED APPROACHCHILDREN YOUNGER187 COUNTRIESDatabase03 medical and health sciencesDatabasesYoung AdultMedicine General & InternalLife ExpectancyGeneral & Internal MedicinemedicineLife ScienceHumansMortalitySex DistributionPreschoolFactualVLAGAgedScience & TechnologyModels Statisticalbusiness.industryPreventionPOPULATION HEALTHInfant NewbornENTERIC MULTICENTERInfantGBD 2013 Mortality and Causes of Death CollaboratorsNewbornVerbal autopsyChild mortalityGood Health and Well BeingLife expectancyRISK-FACTORSbusiness2.4 Surveillance and distributionDemographyModel
researchProduct

Estimating global injuries morbidity and mortality

2020

Background. While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods. In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then est…

MalePopulations/contexts1106 Human Movement and Sports SciencesGlobal injuriespopulation030204 cardiovascular system & hematologyGlobal HealthcontextscontextGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal health1506030212 general & internal medicineOriginal ResearchDatapopulations/contextsIncidence (epidemiology)Incidencemethodology3142 Public health care science environmental and occupational healthPeer reviewFemalePublic HealthTERRITORIESQuality-Adjusted Life Yearsdescriptive epidemiologyHumanDisabilities195 COUNTRIESstatistical issue1117 Public Health and Health Services03 medical and health sciencesAGELife ExpectancyEnvironmental healthInjury preventionSYSTEMATIC ANALYSISstatistical issuesHumansMortalityEstimationSEX-SPECIFIC MORTALITYDISABILITYPublic Health Environmental and Occupational Healthpopulations; contexts; methodology; descriptive epidemiology; statistical issues; Female; Humans; Incidence; Life Expectancy; Male; Morbidity; Quality-Adjusted Life Years; Global Burden of Disease; Global Health; Wounds and Injuriespopulations1106 Human Movement and Sports Sciences 1117 Public Health and Health Services 1701 PsychologyQuality-adjusted life yearYears of potential life lost1701 PsychologyLife expectancyEstimatesWounds and InjuriesHuman medicineMorbiditypopulations/contextInjury prevention
researchProduct

Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomi…

2012

Background and objective: Thrombopoietin receptor (TPOr) agonists (romiplostim and eltrombopag) are a new approach for the treatment of thrombocytopenia-associated conditions. They promote megakaryocyte differentiation, proliferation and platelet production. In the European Union, both are orphan drugs with an indication restricted to splenectomized immune thrombocytopenic purpura patients who are refractory to other treatments. Due to increasing platelet counts, these drugs may represent a risk for thromboembolic complications. We analyzed whether TPOr agonists affect thromboembolisms occurrence in adult thrombocytopenic patients. Materials and methods: We conducted a systematic review and…

Adultmedicine.medical_specialtyMegakaryocyte differentiationRecombinant Fusion ProteinsEltrombopagReceptors FcBenzoateslaw.inventionchemistry.chemical_compoundRandomized controlled triallawRisk FactorsInternal medicineHematologic AgentsThromboembolismmedicinemedia_common.cataloged_instanceHumansEuropean unionmedia_commonRandomized Controlled Trials as TopicRomiplostimbusiness.industryGeneral MedicineNumber needed to harmThrombocytopeniaSurgeryHydrazineschemistryThrombopoietinMeta-analysisRelative riskPyrazolesbusinessReceptors Thrombopoietinmedicine.drugMedicina clinica
researchProduct

Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study.

2016

Background Systematic reviews (SRs) can help decision makers interpret the deluge of published biomedical literature. However, a SR may be of limited use if the methods used to conduct the SR are flawed, and reporting of the SR is incomplete. To our knowledge, since 2004 there has been no cross-sectional study of the prevalence, focus, and completeness of reporting of SRs across different specialties. Therefore, the aim of our study was to investigate the epidemiological and reporting characteristics of a more recent cross-section of SRs. Methods and Findings We searched MEDLINE to identify potentially eligible SRs indexed during the month of February 2014. Citations were screened using pre…

Research designmedicine.medical_specialtyBiomedical ResearchSystematic ReviewsCross-sectional studyMEDLINEResearch and Analysis Methods03 medical and health sciencesDatabase and Informatics Methods0302 clinical medicineMathematical and Statistical TechniquesConDuCT-IIEpidemiologyparasitic diseasesmedicineMedicine and Health SciencesHumansMedical physics030212 general & internal medicineDatabase SearchingStatistical Methods/dk/atira/pure/core/keywords/conduct_iiStatistical DataHealth Care Policybusiness.industryRGeneral MedicinePublication biasResearch Assessment3. Good healthHealth CareReview Literature as TopicSystematic reviewCross-Sectional StudiesData extractionResearch DesignMeta-analysisPhysical SciencesResearch Reporting GuidelinesMedicinebusinessEpidemiologic Methods030217 neurology & neurosurgeryMathematicsStatistics (Mathematics)Screening GuidelinesResearch ArticleMeta-AnalysisPLoS medicine
researchProduct

Additional file 3: of Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies

2017

Definitions of specific cancer-site outcomes. (DOCX 27 kb)

3. Good health
researchProduct

Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Met…

2016

Background Medications aimed at inhibiting the renin–angiotensin system (RAS) have been used extensively for preventing cardiovascular and renal complications in patients with diabetes, but data that compare their clinical effectiveness are limited. We aimed to compare the effects of classes of RAS blockers on cardiovascular and renal outcomes in adults with diabetes. Methods and Findings Eligible trials were identified by electronic searches in PubMed/MEDLINE and the Cochrane Database of Systematic Reviews (1 January 2004 to 17 July 2014). Interventions of interest were angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct renin (DR) inhibitors. T…

ACE inhibitorsMyocardial InfarctionAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyACE inhibitor therapyBiochemistryRenin-Angiotensin SystemAnginachemistry.chemical_compoundEndocrinologyMathematical and Statistical Techniques0302 clinical medicineReninMedicine and Health SciencesSecondary Prevention030212 general & internal medicineMyocardial infarctionDiureticsStrokePharmaceuticsRDrugsEnzyme inhibitorsCardiovascular therapyGeneral Medicine3. Good healthHospitalizationStrokeNephrologyCardiovascular DiseasesPhysical SciencesCardiologyMedicineDrug therapyStatistics (Mathematics)Research Articlemedicine.drugAdultmedicine.medical_specialtyEndocrine DisordersCardiologyResearch and Analysis MethodsAngina PectorisDiabetes ComplicationsAngiotensin Receptor Antagonists03 medical and health sciencesDiabetes mellitusInternal medicineRenal DiseasesDiabetes MellitusmedicineHumansStatistical MethodsRenal Insufficiency ChronicPharmacologyHeart FailureCreatinineBiology and life sciencesbusiness.industryOdds ratiomedicine.diseasechemistryMetabolic DisordersHeart failuresistema cardiovascularACE inhibitorEnzymologyKidney Failure ChronicbusinessMathematicsMeta-AnalysisPLOS Medicine
researchProduct

Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015

2017

IMPORTANCE Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. OBJECTIVE To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. DESIGN A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted va…

MalePediatricsMyocardial IschemiaNormal DistributionPROGRESSIONBlood Pressure030204 cardiovascular system & hematologyGlobal Health0302 clinical medicineCause of DeathPrevalence030212 general & internal medicineStrokeCause of deathAged 80 and overMortality rateUncertaintyGeneral Medicine11 Medical And Health SciencesMiddle AgedStrokeCARDIOVASCULAR-DISEASEHypertensionCardiologyBlood pressureHipertensióFemaleQuality-Adjusted Life YearsARTERIAL STIFFNESSLife Sciences & BiomedicineIntracranial HemorrhagesMonte Carlo MethodAdultmedicine.medical_specialtySystolePressió sanguíniaRisk Assessment03 medical and health sciencesMedicine General & InternalAGEAge DistributionInternal medicineGeneral & Internal MedicinemedicineDisability-adjusted life yearHumansCORONARY-HEART-DISEASESystoleRenal Insufficiency ChronicSex DistributionMETAANALYSISAgedScience & Technologybusiness.industryMORTALITYKIDNEY-DISEASEmedicine.diseaseHealth SurveysQuality-adjusted life yearBlood pressureArterial stiffnessRISK-FACTORSbusiness
researchProduct

Measuring the burden of disease and injury in Spain using disability-adjusted life years: An updated and policy-oriented overview

2011

Summary Objective To provide a comprehensive and detailed overview of the burden of disease in Spain for 2008. Implications for public health policies are discussed. Study design Cross-sectional population-based study. Methods Disability-adjusted life years (DALYs) were calculated at country level using the methodology developed in the Global Burden of Disease study. DALYs were divided into years of life lost and years of life lived with disability. Results were obtained using Spanish mortality data for 2008 and morbidity data estimated previously by the World Health Organization for Euro-A. Results In 2008, DALYs lost due to all diseases and injuries were estimated at 5.1 million. Non-comm…

AdultMaleGerontologymedicine.medical_specialtyAdolescentCross-sectional studyPopulationPopulation healthYoung AdultCost of IllnessCause of DeathEnvironmental healthHumansMedicineDisabled PersonsChildeducationHealth policyDepression (differential diagnoses)Agededucation.field_of_studybusiness.industryHealth PolicyPublic healthPublic Health Environmental and Occupational HealthInfantGeneral MedicineMiddle AgedQuality-adjusted life yearCross-Sectional StudiesYears of potential life lostSpainChild PreschoolWounds and InjuriesFemaleQuality-Adjusted Life YearsbusinessPublic Health
researchProduct

Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from th…

2020

Incluye: Correction: Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017. Inj Prev. 2020 Oct;26(Supp 1):i164. doi: 10.1136/injuryprev-2019-043296corr1. Epub 2020 Sep 28. PMID: 32989004 Background: The epidemiological transition of non-communicable diseases replacing infectious diseases as the main contributors to disease burden has been well documented in global health literature. Less focus, however, has been given to the relationship between sociodemographic changes and injury. The aim of this study was to examine the association between disability-adjuste…

Epidemiologyburden of disease; descriptive epidemiology; epidemiologyECONOMIC-DEVELOPMENT1106 Human Movement and Sports SciencesPoison controlburden of diseaseGlobal HealthGlobal Burden of Disease0302 clinical medicineQuality-Adjusted Life YearGlobal health030212 general & internal medicine10. No inequality1. No povertyBurden of diseaseDALYS3142 Public health care science environmental and occupational healthddc:3. Good healthDescriptive epidemiologyEpidemiological transitionREGISTRATIONDisabled PersonepidemiologyPublic Healthdescriptive epidemiologyHumanmedicine.medical_specialtyDEATHSAdolescent1117 Public Health and Health Services03 medical and health sciencesLife ExpectancyInjury preventionSYSTEMATIC ANALYSISmedicineDisability-adjusted life yearDisease burdenEstimationburden of disease descriptive epidemiology epidemiologyMORTALITYPublic healthEPIDEMIOLOGIC TRANSITIONPublic Health Environmental and Occupational Health030208 emergency & critical care medicineTRENDSEXPECTANCY HALE1701 PsychologyWounds and InjuriesHuman medicineDemography
researchProduct

Reporting guidelines for health research: protocol for a cross-sectional analysis of the EQUATOR Network Library

2019

© Author(s) (or their employer(s)) 2019.

Research ReportBiomedical ResearchCross-sectional studyeducationSpecialtyMEDLINEGuidelines as Topic03 medical and health sciences0302 clinical medicineProtocolHumansresearch reportingMedicine1506030212 general & internal medicinePublishingData abstractionMedical educationbusiness.industry1711General MedicineTransparency (behavior)AuthorshipChecklist3. Good healthReview Literature as TopicResearch NetworksResearch DesignMedical Publishing and Peer ReviewScientific CollaborationReporting GuidelinesResearch reportingCitationRaw databusinessNetwork Analysis030217 neurology & neurosurgeryBMJ Open
researchProduct

Additional file 3: of Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of ob…

2019

Methodological Quality Checklist for Prevalence data. (DOCX 28 kb)

3. Good health
researchProduct

PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and P…

2011

medicine.medical_specialtyHRHISbusiness.industryPublic healthHealth PolicyPublic Health Environmental and Occupational HealthInternational healthHealth promotionNursingPolitical scienceHealth caremedicineGlobal healthHealth educationbusinessHealth policyValue in Health
researchProduct

Additional file 2: of Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity diso…

2017

Key terms for PubMed/MEDLINE search. (DOCX 20 kb)

3. Good health
researchProduct

Improving transparency of scientific reporting to increase value and reduce waste in mental health research.

2015

Clinical Trials as TopicBiomedical Researchbusiness.industryMental DisordersGeneral MedicinePublic relationsEnvironmental economicsMental healthTransparency (behavior)030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineResearch DesignMedicineHumans030212 general & internal medicinebusinessScientific reportingRevista de psiquiatria y salud mental
researchProduct

MOESM4 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 4. List of PMID for included articles.

Data_FILESGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

MOESM3 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 3. Reporting checklist.

3. Good health
researchProduct

PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled Trials

2011

Thrombopoietin Receptor AgonistsRandomized controlled trialbusiness.industrylawHealth PolicyMeta-analysisPublic Health Environmental and Occupational HealthMedicinebusinessBioinformaticslaw.inventionValue in Health
researchProduct

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risk…

2015

Summary Background The Global Burden of Disease, Injuries, and Risk Factor study 2013 (GBD 2013) is the first of a series of annual updates of the GBD. Risk factor quantification, particularly of modifiable risk factors, can help to identify emerging threats to population health and opportunities for prevention. The GBD 2013 provides a timely opportunity to update the comparative risk assessment with new data for exposure, relative risks, and evidence on the appropriate counterfactual risk distribution. Methods Attributable deaths, years of life lost, years lived with disability, and disability-adjusted life-years (DALYs) have been estimated for 79 risks or clusters of risks using the GBD 2…

MaleFine particulate matterNutrition and DiseaseMESH : SanitationHealth BehaviorDiseasesMESH: Metabolic DiseasesMESH: Global Health030204 cardiovascular system & hematologyMESH: Risk AssessmentGlobal HealthMESH : Nutritional StatusMESH: Occupational Exposure0302 clinical medicineUnsafe SexMESH: Risk FactorsRisk FactorsVoeding en ZiekteMedicineAir-pollutionMESH : Female030212 general & internal medicineMESH : Risk AssessmentSanitationWasting2. Zero hungerFactors de risc en les malaltiesMedicine (all)[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologiePublic Health Global Health Social Medicine and EpidemiologyGeneral MedicineMESH : Occupational DiseasesMESH: Nutritional StatusAll-cause mortalityMESH : Risk FactorshumanitiesEnvironmental Exposure; Female; Global Health; Health Behavior; Humans; Male; Metabolic Diseases; Nutritional Status; Occupational Diseases; Occupational Exposure; Risk Assessment; Risk Factors; Sanitation; Medicine (all)Tobacco smoking3. Good healthOccupational DiseasesNutritional StatuMESH : Occupational ExposureMESH : Metabolic DiseasesCohortFemalemedicine.symptomRisk assessmentBlood-pressureHumanMESH: Occupational DiseasesRisk factors in diseasesCoronary-heart-diseaseMESH : MaleMESH: Health BehaviorMESH: Environmental ExposureNutritional StatusPopulation healthBody-mass indexRisk Assessment03 medical and health sciencesHousehold cookingMetabolic DiseasesCardiovascular-diseaseEnvironmental healthGeneral & Internal MedicineOccupational Exposureparasitic diseasesLife ScienceMESH: SanitationHumansRisk factorMESH : Health BehaviorVLAGGBD2013MESH: Humansbusiness.industryRisk FactorGlobal Burden of Disease Study; 79 behavioural environmental and occupational and metabolic risksLong-term exposureMESH : HumansCAUSE-SPECIFIC MORTALITYEnvironmental ExposureMESH: MaleMetabolic DiseaseOccupational DiseaseFolkhälsovetenskap global hälsa socialmedicin och epidemiologiMALE BRITISH DOCTORSYears of potential life lostRelative riskMalaltiesMESH : Global HealthOUTDOOR AIR-POLLUTION[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessMESH : Environmental ExposureMESH: FemaleLancet
researchProduct

PHP7 Orphan Drugs for Rare Diseases in the European Union: Bridging the Gap between Drug Development and Unmet Medical Needs?

2011

medicine.medical_specialtyBridging (networking)business.industryHealth PolicyPublic Health Environmental and Occupational HealthOrphan drugDrug developmentFamily medicineEnvironmental healthmedicinemedia_common.cataloged_instanceEuropean unionbusinessmedia_commonValue in Health
researchProduct

Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiologi…

2012

Abstract Background Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed neuropsychiatric disorder in childhood, but the frequency of the condition is not well established in many countries. The aim of the present study was to quantify the overall prevalence of ADHD among children and adolescents in Spain by means of a systematic review and meta-analysis. Methods PubMed/MEDLINE, IME, IBECS and TESEO were comprehensively searched. Original reports were selected if they provided data on prevalence estimates of ADHD among people under 18 years old in Spain and were cross-sectional, observational epidemiological studies. Information from included studies was systematically ex…

medicine.medical_specialtyAdolescentlcsh:RC435-571UnivariateMEDLINEmedicine.diseaseConfidence intervalPsychiatry and Mental healthNeuropsychiatric disorderAttention Deficit Disorder with HyperactivitySpainlcsh:PsychiatryMeta-analysisEpidemiologyPrevalencemedicineHumansAttention deficit hyperactivity disorderObservational studyChildPsychiatryPsychologyRandomized Controlled Trials as TopicResearch ArticleClinical psychology
researchProduct

Mejoria de la transparencia de métodos y resultados en los análisis coste-efectividad de intervenciones para prevenir, tratar y controlar el cáncer

2017

03 medical and health sciences0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisMedicine030212 general & internal medicineGeneral MedicinebusinessHumanitiesMedicina Clínica
researchProduct

Revisiones rápidas para la síntesis de la evidencia

2017

03 medical and health sciences0302 clinical medicinebusiness.industry030503 health policy & servicesMedicine030212 general & internal medicineGeneral Medicine0305 other medical sciencebusinessHumanitiesMedicina Clínica
researchProduct

Fomento del acceso público y del uso compartido de los datos brutos procedentes de la investigación científica

2014

Editorial.

Information Disseminationbusiness.industryResearchmedia_common.quotation_subjectMathematicsofComputing_GENERALPublic relationsGeneralLiterature_MISCELLANEOUSAccess to InformationPublic accessInformationSystems_GENERALPromotion (rank)HumansMedicineEuropean UnionbusinessRaw datamedia_commonMedicina Clínica (English Edition)
researchProduct

Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-a…

2019

© The Author(s) 2019.

medicine.medical_specialtyEpidemiological studyPopulationMEDLINElcsh:MedicineMedicine (miscellaneous)ComorbidityPsycINFOImpulsivityAttention deficit hyperactivity disorder03 medical and health sciences0302 clinical medicineMeta-Analysis as Topicmental disordersProtocolPrevalencemedicineHumansAttention deficit hyperactivity disorder030212 general & internal medicineeducationPsychiatryeducation.field_of_studybusiness.industry030503 health policy & serviceslcsh:Rmedicine.diseaseComorbidityObservational Studies as TopicMeta-analysisCross-Sectional StudiesAttention Deficit Disorder with HyperactivityResearch DesignSpainMeta-analysisSystematic reviewObservational studymedicine.symptom0305 other medical sciencebusinessSystematic Reviews as TopicSystematic Reviews
researchProduct

Potencial sesgo de patrocinio en los análisis coste-efectividad de intervenciones sanitarias: un análisis transversal

2017

Resumen Objetivo Examinar la relación entre la fuente de financiación de los análisis coste-efectividad de intervenciones sanitarias publicados en España y las conclusiones de los estudios. Diseño Estudio descriptivo transversal. Emplazamiento Bases de datos de literatura científica (hasta diciembre de 2014). Participantes (unidad de análisis) Cohorte de análisis coste-efectividad de intervenciones sanitarias publicados en España entre 1989-2014 (n = 223) que presentaran como medida de resultado los años de vida ajustados por calidad (AVAC). Mediciones principales Se establecieron relaciones entre las conclusiones cualitativas de los estudios y el tipo de fuente de financiación utilizando l…

Medicine(all)lcsh:R5-920Años de vida ajustados por calidad030505 public healthCoste-efectividadCost-Benefit AnalysisEspañaGeneral MedicineOriginalesSesgo03 medical and health sciences0302 clinical medicineCross-Sectional StudiesBiasSpainHumansCost-effectivenessQuality-adjusted life years030212 general & internal medicinelcsh:Medicine (General)0305 other medical scienceFamily PracticeDelivery of Health CareAtencion Primaria
researchProduct

MOESM5 of Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

2020

Additional file 5. List of excluded articles.

Data_FILESTheoryofComputation_GENERALGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)3. Good health
researchProduct

Additional file 5: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full differential gene expression meta-analysis results of cancer data. (ZIP 31237 kb)

population characteristicshuman activities
researchProduct

Additional file 3: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD GSEA pre-ranked enrichment results for different molecular signatures (C2, H, GO_BP, GO_CC, and GO_MF). (XLSX 698 kb)

researchProduct

Additional file 5: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full differential gene expression meta-analysis results of cancer data. (ZIP 31237 kb)

population characteristicshuman activities
researchProduct

Additional file 3: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD GSEA pre-ranked enrichment results for different molecular signatures (C2, H, GO_BP, GO_CC, and GO_MF). (XLSX 698 kb)

researchProduct

Additional file 4: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

gProfileR biological process overrepresentation results of the genes contained in the significant intersections of ASD, SDDCs, and ODDCs. (XLSX 233 kb)

researchProduct

Additional file 2: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD differential gene expression meta-analysis results. (CSV 1387 kb)

researchProduct

Additional file 2: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

Full ASD differential gene expression meta-analysis results. (CSV 1387 kb)

researchProduct

Additional file 4: of Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer

2019

gProfileR biological process overrepresentation results of the genes contained in the significant intersections of ASD, SDDCs, and ODDCs. (XLSX 233 kb)

researchProduct